The timed 25-foot walk as an outcome measure for clinical trials in multiple sclerosis: further evidence that a 20% change is clinically meaningful: P583


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles